two new investigational drugs for diabetes

September 2005

You'll hear about two new investigational drugs for diabetes... Pargluva (muraglitazar) and Exubera (inhaled insulin).

Both are being considered for approval this month.

Pargluva is the first in a new class...called glitazars.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

marketing wars over the new sleeping pills
Women's Health Ortho Evra contraceptive patch and reports of deaths due to blood clots
Women's Health which drugs decrease efficacy of oral contraceptives (OCs)
Infectious Diseases CDC just released new guidelines for the 2005-2006 flu season
Diabetes two new investigational drugs for diabetes
a new inhaled corticosteroid called Asmanex
appropriate use of long-acting inhaled beta-agonists for asthma
alternatives to pseudoephedrine
Cholesterol There's confusion about all the different formulations of fenofibrate
Supplements how ginkgo interacts with other drugs
Supplements A new study is raising the question of whether echinacea is useful for the common cold
Dermatology iPledge, an even stricter risk management program for isotretinoin (Accutane, etc)
Pediatrics whether autism is caused by thimerosal in vaccines
Patient Privacy/HIPAA what HIPAA allows when discussing drug therapy
Practice higher risk of hypertension in women taking chronic NSAIDs or acetaminophen